Akynzeo 300-0.5 MG capsules
Ended Awarded
- Contract number
- SPE2DB25FJW92
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,121
Award facts
- Contract value 100% obligated
- $12,121.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for AKYNZEO 300-0.5 mg capsules with a ceiling value of $12,121.31 under a firm fixed-price contract structure. The award, which is not set aside for any socioeconomic category, is scheduled for completion by September 12, 2025, and represents performance at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
The delivery order for AKYNZEO, an antiemetic medication used to prevent chemotherapy-induced nausea and vomiting, exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the federal healthcare supply chain. As a major supplier to military and veteran healthcare systems through the DLA Medical Supply Chain, AmerisourceBergen demonstrates significant capability in fulfilling federal procurement requirements through competitive awards. The parent IDC vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, vaccines, and related medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJW92?
SPE2DB25FJW92 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FJW92 worth?
The government has obligated $12,121 on SPE2DB25FJW92.
Is contract SPE2DB25FJW92 an order under another contract?
Yes. SPE2DB25FJW92 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJW92 competed?
The extent of competition for SPE2DB25FJW92 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award